Trends and disparities in mortality from malignant neoplasms of digestive system and renal failure in the United States, 1999-2023.

11135 Background: Malignancies of the digestive system represent a substantial global health burden, often exacerbated by coexisting renal failure, which complicates therapeutic interventions and significantly elevates mortality risk. This study aims to analyze and interpret annual mortality trends and disparities among adults in the United States from 1999 to 2023, for various demographic and geographic factors. Methods: The mortality data from the CDC WONDER multiple cause of death files for adults aged ≥25 years were used to analyze age-adjusted and crude mortality rates (AAMRs and CMRs) per 1,000,000 through ICD 10 code: C15-C26 (digestive system malignant neoplasms) and ICD 10 code: N17-N19 (renal failure), stratified by year, gender, race/ethnicity, place of death and geography. Joinpoint regression was used to estimate average annual percent change (AAPC) and annual percent change (APC) with 95% confidence intervals (CIs). Statistical significance was defined as p < 0.05. Results: From 1999 to 2023, a total of 164,004 deaths were reported due to malignant neoplasms of the digestive system and renal failure, mostly occurring in medical facility inpatient settings. The overall AAMR increased from 27.58 in 1999 to 36.84 in 2023 (AAPC: 1.17; 95% CI: -0.01 to 2.36; p = 0.05), with an initial decline observed between 2011 and 2017 (APC: -4.91; p < 0.001), followed by a notable increase through 2023 (APC: 8.26; p < 0.001). Men are noted to have higher AAMR than women (42.40 vs 19.19). Adults aged 65 and above experienced the highest CMR (110.96), whereas adults aged 45–64 years exhibited the greatest annual increase (3.19%; p < 0.001). By race, the highest AAMR was among non-Hispanic (NH) Black individuals (53.41), and the lowest was among NH White individuals (25.73). Geographic disparities were evident, with the West region having the highest AAMR (31.80) and the Northeast region having the lowest AAMR (27.77). Non-metropolitan areas showed higher AAMR than metropolitan areas (29.42 vs 27.91). At the state level, the District of Columbia and South Dakota ranked highest, placed in the top 90th percentile during 1999–2020 and 2021–2023, respectively. Conclusions: Mortality related to malignant neoplasms of the digestive system and renal failure has increased over the past two decades, with disproportionate burden among older adults, men, NH Black individuals, those living in non-metropolitan areas, and the West region, underscoring the need for targeted prevention, early detection, and equitable, integrated care. Average annual percent change (AAPC) of neoplasms of digestive system and renal failure related age-adjusted mortality rates in the United States, 1999 to 2023. Variable Deaths AAPC (95%CI) Overall 164,004 1.17 (-0.01 to 2.36)

Authors

Institutions

Publication Details

Journal
Journal of Clinical Oncology
Published
2026-05-27
DOI
https://doi.org/10.1200/jco.2026.44.16_suppl.11135
Primary Topic
Pancreatic and Hepatic Oncology Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Trends and disparities in mortality from malignant neoplasms of digestive system and renal failure in the United States, 1999-2023.

Nikil Kumar, Fnu Urooba, Syed Tasbeel Mehdi, Mahmoud Alothman Agha et al.
Journal of Clinical Oncology
Pancreatic and Hepatic Oncology Research
article

Trends and disparities in mortality from malignant neoplasms of digestive system and renal failure in the United States, 1999-2023.

Nikil Kumar, Fnu Urooba, Syed Tasbeel Mehdi, Mahmoud Alothman Agha, Muhammad Sarim Azad Khan, Kinza Raza, Sunehra Lohana, Nandni Kumari, Vishan Das, Pardeep Kumar
article en

Abstract

11135 Background: Malignancies of the digestive system represent a substantial global health burden, often exacerbated by coexisting renal failure, which complicates therapeutic interventions and significantly elevates mortality risk. This study aims to analyze and interpret annual mortality trends and disparities among adults in the United States from 1999 to 2023, for various demographic and geographic factors. Methods: The mortality data from the CDC WONDER multiple cause of death files for adults aged ≥25 years were used to analyze age-adjusted and crude mortality rates (AAMRs and CMRs) per 1,000,000 through ICD 10 code: C15-C26 (digestive system malignant neoplasms) and ICD 10 code: N17-N19 (renal failure), stratified by year, gender, race/ethnicity, place of death and geography. Joinpoint regression was used to estimate average annual percent change (AAPC) and annual percent change (APC) with 95% confidence intervals (CIs). Statistical significance was defined as p < 0.05. Results: From 1999 to 2023, a total of 164,004 deaths were reported due to malignant neoplasms of the digestive system and renal failure, mostly occurring in medical facility inpatient settings. The overall AAMR increased from 27.58 in 1999 to 36.84 in 2023 (AAPC: 1.17; 95% CI: -0.01 to 2.36; p = 0.05), with an initial decline observed between 2011 and 2017 (APC: -4.91; p < 0.001), followed by a notable increase through 2023 (APC: 8.26; p < 0.001). Men are noted to have higher AAMR than women (42.40 vs 19.19). Adults aged 65 and above experienced the highest CMR (110.96), whereas adults aged 45–64 years exhibited the greatest annual increase (3.19%; p < 0.001). By race, the highest AAMR was among non-Hispanic (NH) Black individuals (53.41), and the lowest was among NH White individuals (25.73). Geographic disparities were evident, with the West region having the highest AAMR (31.80) and the Northeast region having the lowest AAMR (27.77). Non-metropolitan areas showed higher AAMR than metropolitan areas (29.42 vs 27.91). At the state level, the District of Columbia and South Dakota ranked highest, placed in the top 90th percentile during 1999–2020 and 2021–2023, respectively. Conclusions: Mortality related to malignant neoplasms of the digestive system and renal failure has increased over the past two decades, with disproportionate burden among older adults, men, NH Black individuals, those living in non-metropolitan areas, and the West region, underscoring the need for targeted prevention, early detection, and equitable, integrated care. Average annual percent change (AAPC) of neoplasms of digestive system and renal failure related age-adjusted mortality rates in the United States, 1999 to 2023. Variable Deaths AAPC (95%CI) Overall 164,004 1.17 (-0.01 to 2.36)

Journal of Clinical OncologyVol. 44(16_suppl)
Liaquat University of Medical & Health Sciences (PK), King Edward Medical University (PK), Nishtar Medical College and Hospital (PK), Isra University (PK), Allama Iqbal Medical College (PK), Combined Military Hospital (PK), Namal University (PK), Shaheed Mohtarma Benazir Bhutto Medical University (PK), Mediclinic City Hospital (AE), Bilawal Medical College
Good health and well-being
Openalex Percentile: Top 10%
Pancreatic and Hepatic Oncology Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.